Biologic Outsourcing STREAM

31. Integrated Technologies And Glycosylation Tuning In Upstream Bioprocessing 7/1/2025

    Optimize mAb production with innovative cell culture media and feed designs. Explore integrated technologies, intensified fed-batch approaches, and methods to modulate glycosylation profiles in upstream bioprocessing.

32. Introducing The MAST® Autosampling Solution 12/6/2024

    The MAST® Autosampling Solution automates aseptic sample transfers, maintaining sterility while integrating with analytical technologies to provide reliable insights into critical process parameters.

33. Abzena Capacity Update April 2025: ADC 4/21/2025

    In this on-demand presentation, discover how our integrated expertise can help you develop and manufacture dual payload ADCs with optimized efficacy, precision conjugation, and scalable solutions.

34. How MilliporeSigma Promotes Quality And Risk Reduction 10/20/2021

    Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.

35. KBI Biopharma Capacity Update October 2025: Analytical Services 10/15/2025

    Leveraging decades of expertise, analytical capabilities, and regulatory knowledge, we deliver phase-appropriate solutions that streamline development, reduce risk, and accelerate timelines from discovery through commercialization.

36. Master Your mRNA Manufacturing 3/4/2025

    Join pDNA and mRNA specialists as they discuss innovative mRNA manufacturing solutions for your purification challenges, mRNA stability, and overall product quality.

37. A Friendly CDMO Expert: New CEO Outlines AGC Bio's Transformation 3/25/2025

    Experience a friendlier, more reliable approach to biopharmaceutical manufacturing with AGC Biologics, your trusted partner for minimizing risks and fostering collaboration.

38. The Next-Gen Cell Line Development Platform Fueling Biologics Success 5/19/2025

    Whether you're navigating the challenges of complex biologics or seeking a faster path to the clinic, this discussion sheds light on how innovation in CLD can be a game-changer for your pipeline.

39. Abzena Capacity Update October 2025: Large Molecule 10/16/2025

    Accelerate your therapeutic antibody and complex protein development with advanced mammalian cell line platforms that move from DNA to RCB in just 10 weeks.

40. 60-Seconds Of Science 2/20/2026

    Explore the complex biologics journey, featuring expert-led discussions on development, analytics, MSAT, and tech transfer, offering concise, practical insights for busy professionals worldwide.